EWM
AMPE

Empirical Wealth Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Empirical Wealth Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-277
Closed -$5K – 491
2022
Q3 		$5K Hold
277
– – ﹤0.01% 467
2022
Q2 		$14K Hold
277
– – ﹤0.01% 459
2022
Q1 		$39K Hold
277
– – ﹤0.01% 487
2021
Q4 		$47K Hold
277
– – ﹤0.01% 514
2021
Q3 		$138K Hold
277
– – 0.01% 437
2021
Q2 		$139K Buy
+277
New +$149K 0.01% 429

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Empirical Wealth Management's AMPE Position: Q4 2022 in Review

Empirical Wealth Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 277 shares — an estimated $5K sold.

Empirical Wealth Management first reported a position in AMPE in Q2 2021 and held it in 6 quarters. The position peaked at $139K in Q2 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Empirical Wealth Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Empirical Wealth Management sold 277 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $5K.
  • Empirical Wealth Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2021 and held it in 6 quarters.
  • Empirical Wealth Management's Ampio Pharmaceuticals Inc. position peaked at $139K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Empirical Wealth Management's 13F filing for Q4 2022, filed 8 Feb 2023.